Hello,Welcome to icliniq.com.It depends on theextent of disease within the myometrium and endocervical extent.I hope this helps you.Thank you..
Hi, Welcome to icliniq.com. I would suggest going with the Abraxane or Avastin plus Nivolumab combination for the following reasons: Using immunotherapy now, as you do not want to miss the window of opportunity. Being targeted agents, side effects are not going to be a major issue compared to conventional chemotherapy drugs. In my personal experience, Docetaxel in the second-line setting is too much for patients, and quality of life takes a bit of a hit. Targeting VEGF and PD1, plus Abraxane, gives the best possible chance for an optimal outcome.
Hello, Welcome to icliniq.com. Please also provide me with the following details to provide a treatment plan. Depth of myometrial invasion. Lymphovascular invasion- is present or not? Status of the lymph node. Peritoneal or omental sampling is done or not? Pre-operative MRI findings I hope this information will help you.
Hi, Welcome to icliniq.com. The current treatment for early breast cancer is breast conservation surgery and sentinel lymph node (axillary node) sampling. Please find out what modality is being planned to address the axilla, as not all patients need axillary clearance. After breast conservation surgery, radiotherapy is a standard treatment done over three weeks to reduce the risk of future recurrence. Post-operative histology will dictate if your mother needs chemotherapy or not, guided by the grade, size, margins, and lymph node status.
Hello, Welcome to icliniq.com. I understand your concern. Firstly, try to get physically fit by slowly building up your physical endurance. Join a gym and work out regularly, apart from eating healthy. Have your baseline blood work done along with the liver function tests, bone profile, and kidney profile.
Hi, Welcome to icliniq.com. I understand your concern. I have gone through the attachment (attachment removed to protect patient identity). Yes, it is appropriate to use chemotherapy at this juncture. The HER2 (human epidermal growth factor receptor 2) result is mentioned as equivocal.
Hi, Welcome to icliniq.com. I have seen the reports (attachment removed to protect patient identity). Ovarian cancer recurrence is classified normally as platinum-sensitive or platinum-resistant. Since it is more than six months from the initial treatment, it would be classed as platinum sensitive. So the treatment options would be: Carboplatin alone three weekly or Carboplatin plus Paclitaxel three weekly (sometimes four weekly).
Hi, Welcome to icliniq.com. Treatment of choice in this condition is radical radiotherapy using IMRT (intensity modulated radiation therapy) and IGRT (image-guided radiation therapy) technique with concurrent weekly cisplatin chemotherapy..
Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.